ScoreWhy is Lincoln Pharmaceuticals Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
Poor long term growth as Net Sales has grown by an annual rate of 9.03% and Operating profit at 3.19% over the last 5 years
3
Flat results in Dec 25
- ROCE(HY) Lowest at 15.46%
- PBDIT(Q) Lowest at Rs 23.59 cr.
- OPERATING PROFIT TO NET SALES (Q) Lowest at 14.18%
4
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 19-May-26
- Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST and OBV
5
With ROE of 11.2, it has a Fair valuation with a 2 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 28.31%, its profits have fallen by -1.7%
6
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 1.57% over the previous quarter and collectively hold 6.28% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Lincoln Pharma. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Lincoln Pharma. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Lincoln Pharma.
7.62%
0.71
40.14%
Sensex
-4.95%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.61%
EBIT Growth (5y)
0.88%
EBIT to Interest (avg)
57.93
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
0.97
Tax Ratio
23.98%
Dividend Payout Ratio
4.38%
Pledged Shares
0
Institutional Holding
6.28%
ROCE (avg)
21.16%
ROE (avg)
14.03%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
34
Price to Book Value
1.70
EV to EBIT
12.60
EV to EBITDA
10.73
EV to Capital Employed
2.01
EV to Sales
1.56
PEG Ratio
2.17
Dividend Yield
0.28%
ROCE (Latest)
15.97%
ROE (Latest)
11.60%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
PAT(Latest six months)
At Rs 40.23 cr has Grown at 24.36%
DEBTORS TURNOVER RATIO(HY)
Highest at 4.16 times
NET SALES(Q)
Highest at Rs 187.28 cr
-3What is not working for the Company
ROCE(HY)
Lowest at 15.30%
PBT LESS OI(Q)
At Rs 20.90 cr has Fallen at -9.64%
Loading Valuation Snapshot...
Here's what is working for Lincoln Pharma.
Profit After Tax (PAT) - Latest six months
At Rs 40.23 cr has Grown at 24.36%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 187.28 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Debtors Turnover Ratio- Half Yearly
Highest at 4.16 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Lincoln Pharma.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 20.90 cr has Fallen at -9.64%
Year on Year (YoY)MOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
